APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Interventional Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neurovascular Interventional Devices Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchNeurovascular Interventional Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Interventional Devices Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Neurovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Interventional Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Interventional Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neurovascular Interventional Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neurovascular Interventional Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neurovascular Interventional Devices market include Johnson & Johnson, Medtronic PLC, W.L. Gore & Associates, Terumo Corporation, Stryker Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc. and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurovascular Interventional Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurovascular Interventional Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurovascular Interventional Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurovascular Interventional Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurovascular Interventional Devices Segment by Company

Johnson & Johnson

Medtronic PLC

W.L. Gore & Associates

Terumo Corporation

Stryker Corporation

Penumbra, Inc.

Microport Scientific Corporation

Merit Medical Systems, Inc.

Cardinal Health

Boston Scientific Corporation

Abbott Laboratories

Neurovascular Interventional Devices Segment by Type

Embolization Coils

Intrasaccular Devices

Intracranial Stents

Carotid Stents

Flow Diverters

Others

Neurovascular Interventional Devices Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Others

Neurovascular Interventional Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurovascular Interventional Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurovascular Interventional Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurovascular Interventional Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Neurovascular Interventional Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Interventional Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurovascular Interventional Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurovascular Interventional Devices industry.

Chapter 3: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurovascular Interventional Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurovascular Interventional Devices Industry Trends Table 2. Neurovascular Interventional Devices Industry Drivers Table 3. Neurovascular Interventional Devices Industry Opportunities and Challenges Table 4. Neurovascular Interventional Devices Industry Restraints Table 5. Global Neurovascular Interventional Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurovascular Interventional Devices Revenue Share by Company (2021-2026) Table 7. Global Neurovascular Interventional Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Neurovascular Interventional Devices Sales Volume Share by Company (2021-2026) Table 9. Global Neurovascular Interventional Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Neurovascular Interventional Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurovascular Interventional Devices Key Company Manufacturing Base & Headquarters Table 12. Global Neurovascular Interventional Devices Company, Product Type & Application Table 13. Global Neurovascular Interventional Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurovascular Interventional Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Embolization Coils Table 18. Significant Companies of Intrasaccular Devices Table 19. Significant Companies of Intracranial Stents Table 20. Significant Companies of Carotid Stents Table 21. Significant Companies of Flow Diverters Table 22. Significant Companies of Others Table 23. Global Neurovascular Interventional Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Neurovascular Interventional Devices Sales Volume by Type (2021-2026) & (k units) Table 25. Global Neurovascular Interventional Devices Sales Volume by Type (2027-2032) & (k units) Table 26. Global Neurovascular Interventional Devices Sales Volume Share by Type (2021-2026) Table 27. Global Neurovascular Interventional Devices Sales Volume Share by Type (2027-2032) Table 28. Global Neurovascular Interventional Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Neurovascular Interventional Devices Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Neurovascular Interventional Devices Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Neurovascular Interventional Devices Sales Value Share by Type (2021-2026) Table 32. Global Neurovascular Interventional Devices Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Ambulatory Surgical Centers Table 34. Significant Companies of Hospitals Table 35. Significant Companies of Clinics Table 36. Significant Companies of Others Table 37. Global Neurovascular Interventional Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Neurovascular Interventional Devices Sales Volume by Application (2021-2026) & (k units) Table 39. Global Neurovascular Interventional Devices Sales Volume by Application (2027-2032) & (k units) Table 40. Global Neurovascular Interventional Devices Sales Volume Share by Application (2021-2026) Table 41. Global Neurovascular Interventional Devices Sales Volume Share by Application (2027-2032) Table 42. Global Neurovascular Interventional Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Neurovascular Interventional Devices Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Neurovascular Interventional Devices Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Neurovascular Interventional Devices Sales Value Share by Application (2021-2026) Table 46. Global Neurovascular Interventional Devices Sales Value Share by Application (2027-2032) Table 47. Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (k units) Table 49. Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2026) Table 50. Global Neurovascular Interventional Devices Sales by Region (2027-2032) & (k units) Table 51. Global Neurovascular Interventional Devices Sales Market Share by Region (2027-2032) Table 52. Global Neurovascular Interventional Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Neurovascular Interventional Devices Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Neurovascular Interventional Devices Sales Value Share by Region (2021-2026) Table 55. Global Neurovascular Interventional Devices Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Neurovascular Interventional Devices Sales Value Share by Region (2027-2032) Table 57. Global Neurovascular Interventional Devices Market Average Price (USD/unit) by Region (2021-2026) Table 58. Global Neurovascular Interventional Devices Market Average Price (USD/unit) by Region (2027-2032) Table 59. Global Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Global Neurovascular Interventional Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 62. Global Neurovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 63. Global Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 64. Global Neurovascular Interventional Devices Sales Market Share by Country (2027-2032) Table 65. Global Neurovascular Interventional Devices Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Neurovascular Interventional Devices Sales Value Market Share by Country (2021-2026) Table 67. Global Neurovascular Interventional Devices Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Neurovascular Interventional Devices Sales Value Market Share by Country (2027-2032) Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Neurovascular Interventional Devices Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Medtronic PLC Company Information Table 75. Medtronic PLC Business Overview Table 76. Medtronic PLC Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Medtronic PLC Neurovascular Interventional Devices Product Portfolio Table 78. Medtronic PLC Recent Development Table 79. W.L. Gore & Associates Company Information Table 80. W.L. Gore & Associates Business Overview Table 81. W.L. Gore & Associates Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio Table 83. W.L. Gore & Associates Recent Development Table 84. Terumo Corporation Company Information Table 85. Terumo Corporation Business Overview Table 86. Terumo Corporation Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Terumo Corporation Neurovascular Interventional Devices Product Portfolio Table 88. Terumo Corporation Recent Development Table 89. Stryker Corporation Company Information Table 90. Stryker Corporation Business Overview Table 91. Stryker Corporation Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Stryker Corporation Neurovascular Interventional Devices Product Portfolio Table 93. Stryker Corporation Recent Development Table 94. Penumbra, Inc. Company Information Table 95. Penumbra, Inc. Business Overview Table 96. Penumbra, Inc. Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio Table 98. Penumbra, Inc. Recent Development Table 99. Microport Scientific Corporation Company Information Table 100. Microport Scientific Corporation Business Overview Table 101. Microport Scientific Corporation Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 103. Microport Scientific Corporation Recent Development Table 104. Merit Medical Systems, Inc. Company Information Table 105. Merit Medical Systems, Inc. Business Overview Table 106. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio Table 108. Merit Medical Systems, Inc. Recent Development Table 109. Cardinal Health Company Information Table 110. Cardinal Health Business Overview Table 111. Cardinal Health Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Cardinal Health Neurovascular Interventional Devices Product Portfolio Table 113. Cardinal Health Recent Development Table 114. Boston Scientific Corporation Company Information Table 115. Boston Scientific Corporation Business Overview Table 116. Boston Scientific Corporation Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 118. Boston Scientific Corporation Recent Development Table 119. Abbott Laboratories Company Information Table 120. Abbott Laboratories Business Overview Table 121. Abbott Laboratories Neurovascular Interventional Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Abbott Laboratories Neurovascular Interventional Devices Product Portfolio Table 123. Abbott Laboratories Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Neurovascular Interventional Devices Distributors List Table 127. Neurovascular Interventional Devices Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Neurovascular Interventional Devices Product Image Figure 2. Global Neurovascular Interventional Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurovascular Interventional Devices Sales (2021-2032) & (k units) Figure 5. Global Neurovascular Interventional Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Neurovascular Interventional Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Embolization Coils Image Figure 10. Intrasaccular Devices Image Figure 11. Intracranial Stents Image Figure 12. Carotid Stents Image Figure 13. Flow Diverters Image Figure 14. Others Image Figure 15. Global Neurovascular Interventional Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Neurovascular Interventional Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Neurovascular Interventional Devices Sales Volume Share by Type (2021-2032) Figure 18. Global Neurovascular Interventional Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Neurovascular Interventional Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Neurovascular Interventional Devices Sales Value Share by Type (2021-2032) Figure 21. Ambulatory Surgical Centers Image Figure 22. Hospitals Image Figure 23. Clinics Image Figure 24. Others Image Figure 25. Global Neurovascular Interventional Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Neurovascular Interventional Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Neurovascular Interventional Devices Sales Volume Share by Application (2021-2032) Figure 28. Global Neurovascular Interventional Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Neurovascular Interventional Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Neurovascular Interventional Devices Sales Value Share by Application (2021-2032) Figure 31. Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 32. Global Neurovascular Interventional Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Neurovascular Interventional Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Neurovascular Interventional Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 36. North America Neurovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Neurovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Neurovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 42. South America Neurovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Neurovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Neurovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Neurovascular Interventional Devices Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Neurovascular Interventional Devices Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Embolization Coils
  • Intrasaccular Devices
  • Intracranial Stents
  • Carotid Stents
  • Flow Diverters
  • Others
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Medtronic PLC
  • W.L. Gore & Associates
  • Terumo Corporation
  • Stryker Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Merit Medical Systems, Inc.
  • Cardinal Health
  • Boston Scientific Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurovascular Interventional Devices Sales Value (2021-2032)
  4. 1.2.2 Global Neurovascular Interventional Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Neurovascular Interventional Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurovascular Interventional Devices Market Dynamics
  1. 2.1 Neurovascular Interventional Devices Industry Trends
  2. 2.2 Neurovascular Interventional Devices Industry Drivers
  3. 2.3 Neurovascular Interventional Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Interventional Devices Industry Restraints
3 Neurovascular Interventional Devices Market by Company
  1. 3.1 Global Neurovascular Interventional Devices Company Revenue Ranking in 2025
  2. 3.2 Global Neurovascular Interventional Devices Revenue by Company (2021-2026)
  3. 3.3 Global Neurovascular Interventional Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurovascular Interventional Devices Average Price by Company (2021-2026)
  5. 3.5 Global Neurovascular Interventional Devices Company Ranking (2024-2026)
  6. 3.6 Global Neurovascular Interventional Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurovascular Interventional Devices Company Product Type and Application
  8. 3.8 Global Neurovascular Interventional Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurovascular Interventional Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurovascular Interventional Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurovascular Interventional Devices Market by Type
  1. 4.1 Neurovascular Interventional Devices Type Introduction
  2. 4.1.1 Embolization Coils
  3. 4.1.2 Intrasaccular Devices
  4. 4.1.3 Intracranial Stents
  5. 4.1.4 Carotid Stents
  6. 4.1.5 Flow Diverters
  7. 4.1.6 Others
  8. 4.2 Global Neurovascular Interventional Devices Sales Volume by Type
  9. 4.2.1 Global Neurovascular Interventional Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Neurovascular Interventional Devices Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Neurovascular Interventional Devices Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Neurovascular Interventional Devices Sales Value by Type
  13. 4.3.1 Global Neurovascular Interventional Devices Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Neurovascular Interventional Devices Sales Value by Type (2021-2032)
  15. 4.3.3 Global Neurovascular Interventional Devices Sales Value Share by Type (2021-2032)
5 Neurovascular Interventional Devices Market by Application
  1. 5.1 Neurovascular Interventional Devices Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Neurovascular Interventional Devices Sales Volume by Application
  7. 5.2.1 Global Neurovascular Interventional Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neurovascular Interventional Devices Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Neurovascular Interventional Devices Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Neurovascular Interventional Devices Sales Value by Application
  11. 5.3.1 Global Neurovascular Interventional Devices Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Neurovascular Interventional Devices Sales Value by Application (2021-2032)
  13. 5.3.3 Global Neurovascular Interventional Devices Sales Value Share by Application (2021-2032)
6 Neurovascular Interventional Devices Regional Sales and Value Analysis
  1. 6.1 Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurovascular Interventional Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Neurovascular Interventional Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Neurovascular Interventional Devices Sales by Region (2027-2032)
  5. 6.3 Global Neurovascular Interventional Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurovascular Interventional Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurovascular Interventional Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurovascular Interventional Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Neurovascular Interventional Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurovascular Interventional Devices Sales Value (2021-2032)
  12. 6.6.2 North America Neurovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurovascular Interventional Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Neurovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurovascular Interventional Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurovascular Interventional Devices Sales Value (2021-2032)
  21. 6.9.2 South America Neurovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurovascular Interventional Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
7 Neurovascular Interventional Devices Country-level Sales and Value Analysis
  1. 7.1 Global Neurovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurovascular Interventional Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurovascular Interventional Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Neurovascular Interventional Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Neurovascular Interventional Devices Sales by Country (2027-2032)
  6. 7.4 Global Neurovascular Interventional Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurovascular Interventional Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurovascular Interventional Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Medtronic PLC
  8. 8.2.1 Medtronic PLC Company Information
  9. 8.2.2 Medtronic PLC Business Overview
  10. 8.2.3 Medtronic PLC Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
  12. 8.2.5 Medtronic PLC Recent Developments
  13. 8.3 W.L. Gore & Associates
  14. 8.3.1 W.L. Gore & Associates Company Information
  15. 8.3.2 W.L. Gore & Associates Business Overview
  16. 8.3.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
  18. 8.3.5 W.L. Gore & Associates Recent Developments
  19. 8.4 Terumo Corporation
  20. 8.4.1 Terumo Corporation Company Information
  21. 8.4.2 Terumo Corporation Business Overview
  22. 8.4.3 Terumo Corporation Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
  24. 8.4.5 Terumo Corporation Recent Developments
  25. 8.5 Stryker Corporation
  26. 8.5.1 Stryker Corporation Company Information
  27. 8.5.2 Stryker Corporation Business Overview
  28. 8.5.3 Stryker Corporation Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
  30. 8.5.5 Stryker Corporation Recent Developments
  31. 8.6 Penumbra, Inc.
  32. 8.6.1 Penumbra, Inc. Company Information
  33. 8.6.2 Penumbra, Inc. Business Overview
  34. 8.6.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
  36. 8.6.5 Penumbra, Inc. Recent Developments
  37. 8.7 Microport Scientific Corporation
  38. 8.7.1 Microport Scientific Corporation Company Information
  39. 8.7.2 Microport Scientific Corporation Business Overview
  40. 8.7.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  42. 8.7.5 Microport Scientific Corporation Recent Developments
  43. 8.8 Merit Medical Systems, Inc.
  44. 8.8.1 Merit Medical Systems, Inc. Company Information
  45. 8.8.2 Merit Medical Systems, Inc. Business Overview
  46. 8.8.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
  48. 8.8.5 Merit Medical Systems, Inc. Recent Developments
  49. 8.9 Cardinal Health
  50. 8.9.1 Cardinal Health Company Information
  51. 8.9.2 Cardinal Health Business Overview
  52. 8.9.3 Cardinal Health Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
  54. 8.9.5 Cardinal Health Recent Developments
  55. 8.10 Boston Scientific Corporation
  56. 8.10.1 Boston Scientific Corporation Company Information
  57. 8.10.2 Boston Scientific Corporation Business Overview
  58. 8.10.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  60. 8.10.5 Boston Scientific Corporation Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurovascular Interventional Devices Value Chain Analysis
  2. 9.1.1 Neurovascular Interventional Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurovascular Interventional Devices Sales Mode & Process
  6. 9.2 Neurovascular Interventional Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurovascular Interventional Devices Distributors
  9. 9.2.3 Neurovascular Interventional Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst